InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by TZIANABOS ARTHUR, Chairman & CEO. Insider active across 1 companies, notably Homology Medicines, Inc.. Aggregated, 2 reports have been published. Regulator: SEC (Form 4). All data is free.
Declarations2 total
13,860 shares
Common Stock
SEC:0000899243-22-001743·
13,860 shares
Common Stock
SEC:0000899243-22-001743:0·
2 of 2 declarations
About TZIANABOS ARTHUR
Arthur Tzianabos is the Chief Executive Officer of Homology Medicines, Inc. In this role, he leads the company's operations and strategy in the field of gene therapies. His expertise in this sector enables him to drive innovative initiatives to improve treatments offered to patients.
